A Personalized Bleeding-Avoidance Strategy Can Reduce PCI Bleeding Rates

Selective use of a bleeding-avoidance strategy in high-risk patients lowered the bleeding rate with percutaneous coronary interventions in an observational study.

To encourage the use of bleeding-avoidance strategies (BAS) based on individual risk in patients undergoing percutaneous coronary interventions, investigators conducted a nine-center study using a validated risk model (American College of Cardiology/National Cardiovascular Data Registry) and proprietary software invented by one of the authors. Risk assessment was followed by generation of personalized consent forms and implementation of decision support tools. The researchers compared the use of BAS and bleeding rates during the year before implementation of the personalized risk estimates (7408 procedures) and the year after (3529 procedures).

Overall, BAS use increased from 81% to 89% after implementation (odds ratio, 1.81; 95% confidence …

Reviewing Author

Howard C. Herrmann, MD

Disclosures

Consultant/Advisory BoardAffluent Medical; Artedrone; Caranx; Johnson & Johnson; Medtronic; Prolifagen; Wells Fargo

EquityMicrointerventional Devices, Inc.

RoyaltiesUniversity of Pennsylvania

Grant/Research SupportAbbott Vascular; Edwards Lifesciences; Johnson & Johnson; Medtronic

Editorial BoardsCatheterization and Cardiovascular Interventions; Journal of the American College of Cardiology; Circulation: Cardiovascular Interventions; JACC Cardiovascular Interventions; JACC Case Reports; JSCAI

Leadership Positions in Professional SocietiesHeart Valve Collaboratory (Scientific Committee Member, Chair of the Publications Committee)